Menu Close

Trending

Merck makes circular RNA play with $3.5bn Orna alliance
On heels of new data, Gilead pays $455m for Asian Trodelvy rights
Roche eyes April FDA verdict on Polivy as first-line lymphoma therapy
Digital health’s rapid growth spurt comes home to roost
FDA grants swift review to Lynparza in first-line prostate cancer

Natalie Yeadon

life sciences

Patients/ Views & Analysis/ Views and analysis

Transparency, social change can help pharma regain the public’s trust

, , , , 0 Comment

Trust in life science companies has fluctuated since the start of the pandemic. The reputation of COVID-19 vaccine

X
Transparency, social change can help pharma regain the public’s trust
https://pharmaphorum.com/patients/transparency-social-change-can-help-pharma-regain-the-publics-trust/
diversity and inclusion

Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Importance of diversity in pharma and clinical trials

, , , , , 0 Comment

“Diversity.” It’s a word that is very commonly thrown around right now, not just in pharma and healthcare

X
Importance of diversity in pharma and clinical trials
https://pharmaphorum.com/r-d/importance-diversity-pharma-and-clinical-trials-impetus/
Refining digital collaboration

Deep Dive/ Sales and Marketing/ Views & Analysis/ Views and analysis

Refining digital collaboration

, , , , , 0 Comment

Pharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to

X
Refining digital collaboration
https://pharmaphorum.com/sales-marketing/refining-digital-collaboration/
Why the next blockbuster in mental health might be a video game

Digital/ Views & Analysis/ Views and analysis

Gamification for patient care, medical education, and virtual engagement

, , , , 0 Comment

“Gamification” – adding game-like elements into non-game or real-world settings – has become a popular concept in the

X
Gamification for patient care, medical education, and virtual engagement
https://pharmaphorum.com/views-and-analysis/gamification-for-patient-care-medical-education-and-virtual-engagement/
Why virtual collaboration and medical education will persist in the new normal

Digital/ Views & Analysis/ Views and analysis

10 reasons why virtual collaboration and medical education will persist in the new normal

, , , , 0 Comment

While the effects of COVID-19 have been devastating for many industries, its positive impact on accelerating the uptake

X
10 reasons why virtual collaboration and medical education will persist in the new normal
https://pharmaphorum.com/views-analysis-digital/why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/
Secondary-effects-of-COVID-19-on-the-pharma-healthcare-and-patients

Digital/ Oncology/ Views & Analysis/ Views & Analysis/ Views and analysis

Secondary effects of COVID-19 on pharma, healthcare and patients

, , , 0 Comment

Reminders of the impact of the COVID-19 pandemic on our healthcare system, economy, and day-to-day lives are everywhere.

X
Secondary effects of COVID-19 on pharma, healthcare and patients
https://pharmaphorum.com/views-analysis-digital/secondary-effects-of-covid-19-on-pharma-healthcare-and-patients/
1 2

Login

CONTINUE TO SITE >
X
Close in 10 seconds